Lornoxicam MedChemExpress (MCE)

Product Name	Lornoxicam
Synonyms	LORNOXICAM AKOS 93662 Lornoxicam AKOS 93662 LornoxicaM API LornoxicaM (Xefo) chlortenoxicam Synonyms LORNOXICAM AKOS 93662 Lornoxicam AKOS 93662 LornoxicaM API LornoxicaM (Xefo) chlortenoxicam ridinyl-,1,1-dioxide LornoxicaM for injection hydroxy-2-methyl-n-2-py LornoxicamConsultedStandard 6-Chloro-4-hydroxy-2-Methyl-N-2-pyridinyl- E]-1,2-THIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE 2h-thieno(2,3-e)-1,2-thiazine-3-carboxamide,6-chloro-4- 6-CHLORO-4-HYDROXY-2-METHYL-N-2-PYRIDINYL-2H-THIENO[2,3- 6-Chloro-4-hydroxy-2-Methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxaMide 6-Chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide 6-chloro-4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide 6-Chloro-4-hydroxy-2-methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide-1,1-dioxide (3E)-6-chloro-3-[hydroxy(pyridin-2-ylamino)methylidene]-2-methyl-2,3-dihydro-4H-thieno[2,3-e][1,2]thiazin-4-one 1,1-dioxide
CAS	70374-39-9
EINECS	630-354-7
Chemical Formula	C13H10ClN3O4S2
Molecular Weight	371.82
inchi	InChI=1/C13H10ClN3O4S2/c1-17-10(13(19)16-9-4-2-3-5-15-9)11(18)12-7(23(17,20)21)6-8(14)22-12/h2-6,18H,1H3,(H,15,16,19)
Package	10 mM * 1 mL;100 mg;200 mg;500 mg
Price	Email to quote
Descriptions	Lornoxicam Lornoxicam MedChemExpress (MCE) HY-B0367 70374-39-9 Chlortenoxicam Descriptions Lornoxicam Lornoxicam MedChemExpress (MCE) HY-B0367 70374-39-9 Chlortenoxicam Ro 13-9297 99.36% Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year Room temperature in continental US may vary elsewhere. Lornoxicam (Chlortenoxicam) is an orally active oxycontin nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, antipyretic and anticancer activities. Lornoxicam exhibits good inhibitory effects on both COX-1 and COX-2 (COX-1: IC50=0.005 μM COX-2:IC50=0.008 μM) and inhibits the production of NO by iNOS (IC50=65 μM) and the proinflammatory cytokine IL-6 (IC50=54 μM). Lornoxicam also inhibits tumor cell proliferation and migration and induces tumor cell apoptosis. Lornoxicam can be used in the study of inflammatory pain, colorectal cancer and breast cancer. Lornoxicam (0.03-3 μM 24 h) dose-dependently inhibites the formation of TXB2 in HEL cells, the formation of PGF1 in Mono Mac 6 cells stimulated by LPS (HY-D1056) and the accumulation of NO in the supernatant of RAW 264.7 cells stimulated by LPS (HY-D1056)[6]. Lornoxicam (10-300 μM 10 min) dose-dependently inhibites the formation of IL-6 in human monocytic THP-1 cells (IC50=54 μM) and weakly stimulates the production of TNF-a, IL-1b and IL-8 at a dose of 300 μM[6]. Lornoxicam (3.1-400 μg/mL 0-48 h) concentration-dependently induces a decrease in the viability of cervical cancer, colorectal cancer, and breast cancer cell lines HeLa, MCF-7, and HT-29 and inhibites the proliferation of HT-29 cell line[7]. Lornoxicam (400 μg/mL 24 h) induces apoptosis in HT-29 and MCF-7 tumor cells[7]. Lornoxicam (400 μg/mL 0-72 h) inhibites the migration of HT-29 and MCF-7 tumor cells[7]. Lornoxicam (1.3 mg/kg, i.p. single dose) reduces the ability of central sensitization in rats to reduce hyperalgesia in the thermal hind paw hyperalgesia model[3]. COX-1 5 nM (IC50, in cells) COX-2 45 nM (IC50, in cells) \| \| \| \| \| \| \| \| \| \| [1]. Spyra S, et al. COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels. Br J Pharmacol. 2017 Aug 174(16):2696-2705. [Content Brief] [2]. Rose, P. and C. Steinhauser, Comparison of Lornoxicam and Rofecoxib in Patients with Activated Osteoarthritis (COLOR Study). Clin Drug Investig, 2004. 24(4): p. 227-36. [Content Brief] [3]. Bianchi, M. and A.E. Panerai, Effects of lornoxicam, piroxicam, and meloxicam in a model of thermal hindpaw hyperalgesia induced by formalin injection in rat tail. Pharmacol Res, 2002. 45(2): p. 101-5. [Content Brief] [4]. Balfour J A, et al. Lornoxicam: a review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions[J]. Drugs, 1996, 51: 639-657. [Content Brief] [5]. Pohlmeyer-Esch G, et al. Evaluation of chronic oral toxicity and carcinogenic potential of lornoxicam in rats[J]. Food and chemical toxicology, 1997, 35(9): 909-922. [Content Brief] [6]. Berg J, et al. The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro[J]. Inflammation Research, 1999, 48: 369-379. [Content Brief] [7]. Marinov L, et al. The effects of meloxicam, lornoxicam, ketoprofen, and dexketoprofen on human cervical, colorectal, and mammary carcinoma cell lines[J]. Pharmacia, 2024, 71: 1-12.
Supplier Website	https://www.medchemexpress.com/Lornoxicam.html
Last Update	2025-05-21 16:50:25

MedChemExpress (MCE) also provides

Glycyl-L-glutamine

Category: Natural Products
CAS: 13115-71-4
Last Update: 2025-05-21 16:50:25

Triose phosphate

Category: Natural Products
CAS: 591-57-1
Last Update: 2025-05-21 16:50:25

Lactyl-CoA

Category: Natural Products
CAS: 1926-57-4
Last Update: 2025-05-21 16:50:25

12(S)-HPETE

Category: Natural Products
CAS: 71774-10-2
Last Update: 2025-05-21 16:50:25

Pyrithiamine

Category: Natural Products
CAS: 534-64-5
Last Update: 2025-05-21 16:50:25

alpha-CEHC

Category: Natural Products
CAS: 4072-32-6
Last Update: 2025-05-21 16:50:25

Maltoheptaose

Category: Natural Products
CAS: 34620-78-5
Last Update: 2025-05-21 16:50:25

Phenoxyethanol

Category: Natural Products
CAS: 122-99-6
Last Update: 2025-05-21 16:50:25


Supplier Name	MedChemExpress (MCE)
Contact	sales
Tel	609-228-6898
Mobile	609-228-6898
QQ
Email	sales@medchemexpress.com; tech@medchemexpress.com
Website	https://www.medchemexpress.com/
Wechat

Request for quotation

Supplier Contact